Acción A004720 PHARMGEN SCIENCE, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas PharmGen Science, Inc.

Acciones

A004720

KR7004720009

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 08/05/2024 		Varia. Cinco días. Varia. 1 de enero.
5.370 KRW +0,56 % Gráfico intradía de PharmGen Science, Inc. +0,94 % -13,39 %
2023 PharmGen Science, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index
PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
PharmGen Science Inc. announced that it has received KRW 20 billion in funding from Meritz Securities Co., Ltd.
PharmGen Science Inc. announced that it expects to receive KRW 20 billion in funding from Meritz Securities Co., Ltd.
PharmGen Science Inc. announced that it has received KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
PharmGen Science Inc. announced that it expects to receive KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
MÄRKTE ASIEN/Impulsloser Handel mit wenig Bewegung bei Aktien
Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
Wooridul Pharmaceutical Limited(KOSE:A004720) added to S&P Global BMI Index
Wooridul Pharmaceutical Limited cancelled the acquisition of 11.6% stake in Access Bio, Inc. from Youngho Choi.
HD Fund signed a stock transfer agreement to acquire 6.4% stake in Wooridul Pharmaceutical Limited from Soo-Kyung Kim for KRW 12 billion.
Access Bio, Inc. announced that it has received KRW 9.999999142 billion in funding from Wooridul Pharmaceutical Limited
Wooridul Pharmaceutical Limited signed a contract to acquire 11.6% stake in Access Bio, Inc. from Youngho Choi for KRW 17 billion.
Access Bio, Inc. announced that it expects to receive KRW 9.999999142 billion in funding from Wooridul Pharmaceutical Limited
Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Choeun Mutual Savings Bank, Investment Arm, Hana Capital Co., Ltd., and other investors
Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Choeun Mutual Savings Bank, Investment Arm, Hana Capital Co., Ltd., and other investors.
Miev Co., Ltd. announced that it has received KRW 1 billion in funding from Wooridul Pharmaceutical Limited
Miev Co., Ltd. announced that it expects to receive KRW 1 billion in funding from Wooridul Pharmaceutical Limited
Wooridul Pharmaceutical Limited(KOSE:A004720) dropped from S&P Global BMI Index
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A004720
  4. Noticias PharmGen Science, Inc.
  5. Otros idiomas